#1 Clinical Trials Search in Europe

Iron

Iron supplementation is a crucial treatment for iron deficiency and anemia across various patient populations. This article examines several clinical trials investigating different forms of iron supplementation, including oral and intravenous formulations, in populations such as preterm infants, inflammatory bowel disease patients, pregnant women, and dialysis patients. The studies aim to evaluate the efficacy, safety, and tolerability of various iron preparations in treating iron deficiency and anemia.

Table of Contents

What is Iron and Why is it Important?

Iron is an essential micronutrient that plays a crucial role in many bodily functions. It is a key component of hemoglobin, the protein in red blood cells that carries oxygen throughout your body. When you don’t have enough iron, your body can’t produce enough healthy red blood cells, leading to a condition called iron deficiency anemia[1].

Iron is vital for:

  • Oxygen transport in the blood
  • Energy production in cells
  • Proper functioning of the immune system
  • Brain development and cognitive function

Conditions Treated with Iron Supplementation

Iron supplementation is used to treat or prevent several conditions, including:

  • Iron Deficiency Anemia (IDA): This is the most common reason for iron supplementation. IDA occurs when the body doesn’t have enough iron to produce adequate hemoglobin[1].
  • Heart Failure: Iron deficiency is common in heart failure patients and can worsen their condition. Iron supplementation may improve symptoms and quality of life in these patients[2].
  • Inflammatory Bowel Disease (IBD): Patients with conditions like ulcerative colitis often experience iron deficiency due to chronic blood loss and poor iron absorption[3].
  • Chronic Kidney Disease (CKD): Anemia is a common complication in CKD patients, often requiring iron supplementation[1].
  • Pregnancy and Postpartum: Pregnant women and those who have recently given birth often need additional iron to support increased blood volume and fetal development[1].

Types of Iron Supplements

There are several types of iron supplements available, including:

  • Oral Iron: These include ferrous sulfate, ferrous gluconate, and ferric maltol (Feraccru). Oral iron is often the first-line treatment due to its convenience and lower cost[1].
  • Intravenous (IV) Iron: This includes preparations like iron sucrose (Venofer), iron carboxymaltose, and iron dextran. IV iron is typically used when oral iron is not effective or not tolerated[1][4].
  • Sucrosomial Iron: This is a newer form of oral iron that may have better absorption and fewer side effects[3].

How Iron Supplements are Administered

The method of administration depends on the type of iron supplement:

  • Oral Iron: Usually taken as tablets or liquid, often 1-3 times daily. It’s best absorbed on an empty stomach, but can be taken with food if it causes stomach upset[4].
  • Intravenous Iron: Administered in a medical setting as an infusion or injection. The dosage and frequency depend on the specific product and the patient’s needs[4].

Efficacy of Iron Supplementation

The effectiveness of iron supplementation can vary depending on the individual and the underlying cause of iron deficiency. In general:

  • Oral iron can be effective in many cases, but may take several months to fully replenish iron stores[4].
  • Intravenous iron can raise iron levels more quickly and may be more effective in certain conditions, such as inflammatory bowel disease where oral iron absorption may be impaired[4].
  • In heart failure patients, iron supplementation has been shown to improve symptoms and quality of life[2].

Potential Side Effects and Tolerability

Iron supplements can cause side effects, which vary depending on the type and route of administration:

  • Oral Iron: Common side effects include constipation, diarrhea, nausea, abdominal pain, and dark stools. These side effects can sometimes lead to poor compliance with treatment[4].
  • Intravenous Iron: Generally well-tolerated but can occasionally cause reactions such as headache, dizziness, or allergic reactions. Serious side effects are rare but can include anaphylaxis[4].
  • Sucrosomial Iron: May have fewer gastrointestinal side effects compared to traditional oral iron, potentially improving tolerability[3].

Iron Supplementation in Special Populations

Certain groups may require special consideration when it comes to iron supplementation:

  • Preterm Infants: Very low birth weight infants may require iron supplementation to prevent iron deficiency, but care must be taken to avoid iron overload[5].
  • Patients with Liver Disease: Iron supplementation in patients awaiting liver transplantation may help reduce the need for blood transfusions during surgery[6].
  • Inflammatory Bowel Disease Patients: May require different approaches to iron supplementation due to potential issues with oral iron absorption and tolerability[3].

Ongoing Research and Future Directions

Research into iron supplementation is ongoing, with several areas of focus:

  • Comparing the efficacy and tolerability of different iron formulations in various patient populations[3][4].
  • Investigating the role of iron supplementation in heart failure patients[2].
  • Exploring new formulations of iron supplements that may offer better absorption and fewer side effects[3].
  • Studying the long-term effects of iron supplementation on patient outcomes and quality of life[1].

As research progresses, our understanding of how best to use iron supplements to treat various conditions continues to improve, potentially leading to better outcomes for patients with iron deficiency.

Study Population Iron Formulations Key Outcomes Measured
Preterm infants Oral iron supplementation Iron status, hemoglobin levels, safety
Ulcerative colitis patients Sucrosomial iron vs. oral iron sulfate Tolerability, efficacy in treating anemia
Inflammatory bowel disease patients Intravenous iron sucrose vs. oral iron sulfate Efficacy, tolerability, impact on disease activity
Hemodialysis patients Intravenous vs. oral iron therapy Hemoglobin levels, erythropoietin dose requirements
Blood donors Sucrosomial iron vs. iron sulfate Side effects, maintenance of iron balance
Pregnant women Iron supplementation vs. placebo Prevention of anemia, hemoglobin levels
Peritoneal dialysis patients Iron isomaltoside vs. iron sucrose Patient satisfaction, efficacy, safety
Celiac disease patients Sucrosomial iron vs. iron sulfate Efficacy in treating iron deficiency anemia

FAQ

  • What are the different forms of iron supplementation being studied? The clinical trials are studying various forms of iron supplementation, including oral iron sulfate, intravenous iron sucrose, iron isomaltoside, sucrosomial iron, and lactoferrin. Both oral and intravenous routes of administration are being investigated.
  • Which patient populations are being studied in these iron supplementation trials? The trials are investigating iron supplementation in diverse patient groups, including preterm infants, patients with inflammatory bowel disease (such as ulcerative colitis), pregnant women, hemodialysis and peritoneal dialysis patients, and blood donors.
  • What are the main goals of these iron supplementation studies? The main goals of these studies include assessing the efficacy of iron supplementation in treating iron deficiency and anemia, comparing different iron formulations, evaluating safety and tolerability, and investigating the effects on quality of life and other clinical outcomes.
  • How is the effectiveness of iron supplementation measured in these trials? The effectiveness of iron supplementation is measured through various outcomes, including changes in hemoglobin levels, iron saturation, ferritin levels, and other iron status markers. Some studies also assess patient-reported outcomes, such as fatigue and quality of life.
  • What are some potential side effects of iron supplementation being monitored? The trials are monitoring for various side effects, including gastrointestinal symptoms (such as nausea, vomiting, constipation, and diarrhea), allergic reactions, and potential impacts on underlying conditions like inflammatory bowel disease. Some studies are also investigating the long-term safety of iron supplementation.

Ongoing Clinical Trials on Iron

  • Study on Daily vs. Alternate Day Iron Supplements for Treating Iron Deficiency Anemia in Pregnant Women

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Ireland

Glossary

  • Anemia: A condition in which there are not enough healthy red blood cells to carry adequate oxygen to the body's tissues, often caused by iron deficiency.
  • Ferritin: A protein in the body that stores iron and releases it when needed. Blood ferritin levels are often used as an indicator of the body's iron stores.
  • Hemoglobin: A protein in red blood cells that carries oxygen throughout the body. Hemoglobin levels are used to diagnose anemia.
  • Iron deficiency: A condition in which the body doesn't have enough iron to produce hemoglobin, leading to anemia if left untreated.
  • Iron saturation: A measure of how much iron is bound to transferrin (a protein that transports iron in the blood). It's used to assess iron status.
  • Intravenous (IV) iron: Iron supplementation given directly into a vein, often used when oral iron is not effective or tolerated.
  • Oral iron: Iron supplements taken by mouth, usually in the form of tablets or liquid.
  • Sucrosomial iron: A new form of oral iron where iron is protected by a phospholipid membrane, designed to improve absorption and reduce side effects.
  • Inflammatory Bowel Disease (IBD): A group of disorders, including Crohn's disease and ulcerative colitis, characterized by chronic inflammation of the digestive tract.
  • Erythropoietin: A hormone produced by the kidneys that stimulates red blood cell production. Often used in conjunction with iron supplementation in certain medical conditions.

References

  1. https://clinicaltrials.gov/study/NCT03382275
  2. https://clinicaltrials.gov/study/NCT05000853
  3. https://clinicaltrials.gov/study/NCT05225545
  4. https://clinicaltrials.gov/study/NCT01067547
  5. https://clinicaltrials.gov/study/NCT01443195
  6. https://clinicaltrials.gov/study/NCT04475887